Improving the response rates to questionnaires. by Smeeth, Liam & Fletcher, Astrid E
Smeeth, L; Fletcher, AE (2002) Improving the response rates to ques-
tionnaires - Several common sense strategies are effective. BMJ, 324
(7347). pp. 1168-9. ISSN 1468-5833 DOI: 10.1136/bmj.324.7347.1168
Downloaded from: http://researchonline.lshtm.ac.uk/17010/
DOI: 10.1136/bmj.324.7347.1168
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/2.5/
1 Clason AE, Stonebridge DA, Duncan AJ, Nolan B, Jenkins AMcL, Ruck›
ley CV. Acute ischaemia of the lower limb: the effect of centralising vascu›
lar surgical services on morbidity and mortality. Br J Surg 1989;76:592›3.
2 Bradbury AW, Makhdoomi KR, Adam DJ, Murie JA, Jenkins AMcL, Ruck›
ley CV. Twelve›year experience of the management of ruptured abdomi›
nal aortic aneurysm. Br J Surg 1997;84:1705›7.
3 Lepäntalo M. Should vascular surgery be centralised or decentralised? A
Nordic point of view. Eur J Vasc Surg 1994;8:116›8.
4 Michaels J, Palfreyman S, Wood R. Evidence›based guidelines for the
configuration of vascular services. J Clin Exc 2001;3:145›53.
5 Vascular Surgical Society of Great Britain and Ireland. The provision of
emergency vascular services. A document prepared for the, London:
Royal College of Surgeons of England, 2001.
6 Basnyat PS, Biffen AHB, Moseley LG, Hedges AR, Lewis MH. Mortality
from ruptured abdominal aortic aneurysm in Wales. Br J Surg
1999;86:765›70.
7 Amundsen S, Skjaerven R, Trippestad A, Soreide O. Abdominal aortic
aneurysms—a study of factors influencing postoperative mortality. Eur J
Vasc Surg 1989;3:405›9.
8 Barros D’Sa AAB. Optimal travel distance before ruptured aortic
aneurysm repair. In: Greenhalgh RM, Mannick JA, Powell JT. Cause and
management of aneurysms. London: Saunders, 1990.
9 Farooq MM, Freischlag JA, Seabrook GR, Moon MR, Aprahamian C,
Towne JB. Effect of the duration of symptoms, transport time and length
of emergency room stay on morbidity and mortality in patients with rup›
tured abdominal aortic aneurysms. Surgery 1996:119;9›14.
10 Cassar K, Godden DJ, Duncan JL. Community mortality after ruptured
abdominal aortic aneurysm is unrelated to distance from the surgical
centre. Br J Surg 2001;88:1341›3.
Improving the response rates to questionnaires
Several common sense strategies are effective
Most readers of the BMJ probably receivepostal questionnaires from time to time.Whether such questionnaires are dutifully
completed and returned, left to gather dust, or rapidly
thrown away may seem like a random process of little
importance. However, while response may be of little
consequence at the individual level, for many research
studies a high response rate to a postal questionnaire is
critical. No matter how expensive, well designed, or
important a study, a poor response rate can introduce
such uncertainty—and worse still, bias—in the results as
to make the study of little scientific value. However,
postal questionnaires are attractive to researchers
because they are likely to be substantially cheaper than
data collection based on interviews. Postal question›
naires are increasingly used in other areas of health
care, for example in screening programmes, to assess
patient satisfaction, or to assess outcomes after
treatments such as surgery. Methods to maximise
response rates from postal questionnaires therefore
have considerable relevance for medical researchers,
practitioners, and policy makers alike.
In this issue Edwards and colleagues present a sys›
tematic review of interventions to improve response
rates to postal questionnaires (p 1183).1 The review
included 292 randomised trials that evaluated 75
different strategies. The scale of the review indicates the
need for high quality, rigorous systematic reviews—
identifying, appraising, and collating such an enor›
mous volume of research would clearly be beyond even
the best intentioned researchers planning to post a
questionnaire. The systematic review identified several
factors that were associated with increased response
rates including monetary incentives; sending the ques›
tionnaires by recorded delivery and by first class post;
short questionnaires; coloured ink; personalised
letters; and follow up contact and second copies. Ques›
tionnaires including questions of a sensitive nature and
those from commercial as opposed to university
sources were less likely to be returned. None of these
factors are likely to surprise readers. However, even
though the review by Edwards and colleagues serves to
confirm many ideas that make sense, it is important
because it provides a firm evidence base for
researchers trying to improve response rates and
therefore the quality of their research.
Some caution is required in interpreting the
findings of the review. Many of the included trials had
nothing to do with health care. This meant that a lot
more trials could be included in the review, allowing
the reviewers to assess a wider range of possible inter›
ventions and greatly increasing the power and
precision of the estimates of effect of these interven›
tions. However, the extent to which findings from, for
example, commercial fields such as marketing can
safely be generalised to a healthcare setting is
questionable. The intervention found to have the
greatest effect on response rates—offering money—
raises a number of ethical considerations and is a strat›
egy that many people in health care would be reluctant
to use, particularly with vulnerable groups. The current
relevance of the findings is also important. Some of the
trials were done some decades ago, when the public
was relatively naive. Personalised letters, coloured inks,
free pens, promises of free gifts, and even gold or silver
envelopes are now routinely used by the commercial
sector to attract the attention of potential customers.
Many recipients may now be immune to such devices.
One clear message that does emerge is the need for
health researchers to make their letter different from
that of commercial organisations.
Edwards and colleagues quite rightly focused on a
single issue: response rates to postal questionnaires.
Their review is the first Cochrane review focusing on
research methodology.2 Systematic reviews addressing
a wide range of other methodology questions are
clearly needed. For example, while postal question›
naires are relatively cheap and high response rates can
be obtained, they are also associated with higher levels
of missing or incomplete responses.3 Choosing
between postal questionnaires and other methods for
collecting data is another important question where
the evidence is unclear, indicating the need for a
systematic review. Much of the research on postal
questionnaires will be irrelevant in some developing
countries, where strategies such as door to door
surveys are more likely to be used. Again, the evidence
about factors associated with higher response rates for
door to door surveys is unclear and a systematic review
would be of great value.
The evidence base for research methodology is
growing fast. An early example was a study showing
that in randomised trials, concealment of allocation
(meaning no one can predict which group participants
will be randomised to) and blinding of outcome assess›
ments were associated with reduced bias.4 Other areas
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such as methods for undertaking systematic reviews
and health services research have substantial litera›
ture.5 6 Such evidence matters because it can improve
the quality of research and ultimately improve clinical
care and health policy. As more is known about the
factors associated with high quality research, it is up to
investigators to make more use of research findings.
The review by Edwards and colleagues is a valuable
step towards making evidence based research a reality.
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Implications of the EU directive on clinical trials for
emergency medicine
Many trials in emergency medicine will not be possible
Alaudable attempt by the European Union toimplement good clinical practice in theconduct of clinical trials on drugs for human
use will, unless amended, make impossible a range of
potentially life saving studies after May 2004.
Directive 2001/20/EC, adopted in April last year, is
an important and comprehensive document.1 It is a
cornerstone of a Europe›wide harmonisation of the
provisions governing clinical trials and can be
expected to foster and facilitate multinational clinical
research. It will be adopted by member states before 1
May 2003, and its provisions will be applied from 1
May 2004 at the latest.
Several articles in the directive deal with the
protection of clinical trial subjects. Article 5 outlines
the conditions for research in incapacitated patients
unable to give informed consent. The article, however,
is framed to address the needs of individuals who are
incapacitated for long periods, many even perma›
nently. A clinical trial can only be done if “informed
consent of the legal representative has been obtained.”
This will be difficult in many emergencies—when
a patient is suddenly and perhaps temporarily
incapacitated.
In some countries, such as the United Kingdom,
there appears to be no provision for a legal
representative for incapacitated patients. This means
the doctor in charge takes responsibility for entering
the patient into the trial. The situation appears to be
similar in Spain and in Norway. In the Netherlands
consent may be given by the life partner, at least in
acute emergencies. In Germany patients may be
enrolled if it can be assumed that the effectiveness of a
treatment appears to be unclear. In other countries
such as Ireland and Austria the situation may be more
difficult. Legal representatives cannot be produced
quickly and usually do not even exist, since a healthy
adult person does not need a legal representative.
Therefore, many studies performed in emergency
medicine will no longer be possible after May 2004.
Acute diseases such as cardiac arrest, major stroke,
or severe trauma are major health burdens. How shall
we assess the effectiveness of healthcare interventions
in patients with such diseases in the future? The direc›
tive may not only affect unconscious people. Thou›
sands of patients with acute myocardial infarction have
been enrolled in clinical trials so far. Many of these
have severe pain on admission and receive treatment
with opiates: can they give informed consent,
particularly those with cardiogenic shock? Research in
the acute care setting is already difficult and this direc›
tive will make it even more difficult.
The provisions of article 5 draw a sorry parallel to
current legislation in Austria regarding the clinical
testing of medical devices. Article 49 of Austria’s Medi›
cal Device Act (implemented in 1996) states that any
clinical study on a medical device can be done only if
the patient has given her or his informed consent. At
first sight, this seems reasonable and clearly in the spirit
of the Helsinki Declaration. No provision exists,
however, for a patient who is temporarily unable to
give consent. Consequently, any device designed for
use in emergency situations, such as cardiopulmonary
resuscitation, cannot be used in a clinical trial
anywhere in Austria.
This legislation has created the absurd situation
that a modern, industrialised country, loyal to the ethi›
cal principles of the Helsinki Declaration, leaves
research and testing of medical devices to other coun›
tries. Austria is ready to use it only after clinicians and
patients in other parts of the world have taken the risk
of researching the intervention. Outside a clinical
study, however, physicians are legally permitted to use
any medical device if they think it is best for their
patients. It seems barely credible that any legislation
can create such an illogical situation for patients and
their doctors.
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